Filing status
- Accounts due
- 30 September 2027
- Last accounts
- 31 December 2025
- Conf. stmt due
- 27 October 2027
- Last conf. stmt
- 13 October 2026
Edwards Lifesciences Limited
- Incorporated
- 18 November 1999 (26 years)
- Previously known as
- Edwards Life Sciences Limited (until 13 January 2000)Intercede 1510 Limited (until 4 January 2000)
- Industry
- Retail sale of medical and orthopaedic goods in specialised stores (not incl. hearing aids) n.e.c. (47749)
- Directors
- Andrew Michael DahlLinda ParkPatrice Lucien Pascal Cappelle
- Owned by
- Edwards Lifesciences Corporation
- Accounts type
- Full
- Region
- Greater London
- Address
- Cannon Place78 Cannon StreetLondonEC4N 6AF
Charges
- Total
- 2
- Outstanding
- 2
- Part satisfied
- 0
- Satisfied
- 0
Officers 3 active
Officer details are public data from the Companies House register.
Dahl, Andrew Michael
Director · Appointed 15 May 2024
American
Born January 1977 (49)
Park, Linda
Director · Appointed 18 May 2018
American
Born December 1977 (48)
Cappelle, Patrice Lucien Pascal
Director · Appointed 18 May 2016
French
Born August 1973 (53)
Officer history (15 former)
31 May 2024
15 May 2024
Appointed Dahl, Andrew Michael as Director
15 May 2024
Resigned Sellers, Robert William Armbruster as Director
9 March 2022
Resigned Walker, Nicholas Mark as Director
18 May 2018
Resigned Botticelli, Denise Ellen as Director
18 May 2018
Appointed Park, Linda as Director
18 May 2016
Appointed Cappelle, Patrice Lucien Pascal as Director
18 May 2016
Resigned Beyrath, Jean-Francois as Director
27 September 2012
Resigned Jones, David Ronald as Director
27 September 2012
Appointed Beyrath, Jean-Francois as Director
5 January 2012
Appointed Botticelli, Denise Ellen as Director
5 January 2012
Resigned Verguet, Patrick Bruno as Director
5 January 2012
Appointed Jones, David Ronald as Director
5 January 2012
Resigned Wertheim, Jay Philip as Director
1 January 2010
Appointed Walker, Nicholas Mark as Director
1 January 2010
Resigned Morrish, Craig as Director
18 July 2007
Resigned Lauret, Raymond Alex as Director
18 July 2007
Appointed Wertheim, Jay Philip as Director
18 July 2007
Appointed Sellers, Robert William Armbruster as Director
18 July 2007
Appointed Verguet, Patrick Bruno as Director
21 September 2006
Resigned Walton, Nicholas Peter as Director
21 September 2006
Appointed Morrish, Craig as Director
28 May 2004
Resigned Ballester, Andre Michel as Director
3 April 2002
Appointed Walton, Nicholas Peter as Director
2 April 2002
Resigned Harty, Mark as Director
24 February 2000
Appointed Harty, Mark as Director
14 January 2000
Appointed Lauret, Raymond Alex as Director
14 January 2000
14 January 2000
14 January 2000
Appointed Ballester, Andre Michel as Director
18 November 1999
18 November 1999
18 November 1999
Ownership 1 active
People and entities with significant control, from the Companies House PSC register
Edwards Lifesciences Corporation
Corporate entity · Notified 6 April 2016
Owns 75–100% of shares
Holds 75–100% of voting rights
Right to appoint and remove directors
Us Corporation
Financials
Figures from 2024 accounts. Newer accounts, made up to 31 December 2025, are filed but not read yet. See them on Companies House
- Net Assets
- £36,200,000
- Cash
- £15,666,000
- Profit Before Tax
- £18,020,000
- Debt Ratio
- 53%
- Current Ratio
- 1.9x
- Return on Equity
- 37%
Trend
Net Assets
Balance sheet detail
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | |
|---|---|---|---|---|---|---|
| Fixed Assets | £237,000 | £344,988 | £366,099 | £537,314 | £577,440 | £566,980 |
| Current Assets | £76,719,000 | £72,765,434 | £38,168,299 | £35,163,778 | £24,580,233 | £25,288,359 |
| Debtors | £41,090,000 | £34,693,936 | £11,268,490 | £8,514,721 | ||
| Cash | £15,666,000 | £18,521,479 | £8,739,360 | £11,637,551 | £5,804,975 | £5,226,478 |
| Creditors (< 1 year) | £40,725,000 | £50,293,773 | £21,275,023 | £22,732,538 | £16,582,533 | £20,447,763 |
| Net Current Assets | £35,994,000 | £22,471,661 | £16,893,276 | £12,431,240 | £7,997,700 | £4,840,596 |
| Net Assets | £36,200,000 | £22,727,733 | £17,247,323 | £12,916,669 | £8,523,332 | £5,355,720 |
| Shareholder Funds | £36,200,000 | £22,727,733 | £17,247,323 | £12,916,669 | £8,523,332 | £5,355,720 |
| Turnover | £126,034,595 | £107,496,555 | £99,229,847 | |||
| Cost of Sales | £170,821,000 | £143,759,439 | £121,824,413 | £106,982,464 | £87,194,345 | £82,624,402 |
| Gross Profit | £19,052,131 | £20,302,210 | £16,605,445 | |||
| Admin Expenses | £20,430,000 | £20,455,662 | £16,530,551 | £14,090,848 | £15,860,578 | £12,229,309 |
| Staff Costs | £13,245,000 | £12,095,442 | £10,561,654 | £9,059,756 | £7,617,582 | £6,638,459 |
| Operating Profit | £5,029,077 | £4,441,632 | £4,376,136 | |||
| Profit Before Tax | £18,020,000 | £6,655,193 | £5,373,602 | £4,991,697 | £4,291,066 | £4,246,820 |
| Tax | £4,505,000 | £1,203,400 | £982,402 | £806,352 | £1,009,478 | £1,342,814 |
| Profit for Period | £13,515,000 | £5,451,793 | £4,391,200 | £4,185,345 | £3,281,588 | £2,904,006 |
Filings
Recent filings only. See the full history on Companies House
| Date | Description | Made Up To | Pages | |
|---|---|---|---|---|
| 5 November 2026 | Confirmation statement with no updates | 13 October 2026 | ||
| 21 October 2026 | Replacement filing of Confirmation Statement | 13 October 2024 | ||
| 15 September 2026 | Full accounts | 31 December 2025 | ||
| 14 October 2025 | Confirmation statement with no updates | 13 October 2025 | 3 | |
| 23 September 2025 | Full accounts | 31 December 2024 |
Some other companies at this address
Other companies in this industry
Weymouth
Rhymney, Tredegar
Bridgend
Huntingdon
Bristol
By trade and location
Explore the largest companies
Need accounts figures, ownership or websites for thousands of companies? Bulk data & API →